Treatment and Adherence Support for Minorities (TRANSFORM)
Research type
Research Study
Full title
A prospective cohort study assessing treatment and adherence support for minorities (TRANSFORM): Mapping Difference in Treatment Patterns and Adherence to Inform Therapy Choice and Improve Support for Black Men with Advanced Prostate Cancer
IRAS ID
333907
Contact name
Robert Horne
Contact email
Sponsor organisation
University College London
Duration of Study in the UK
1 years, 8 months, 30 days
Research summary
The aim of this research is to better understand differences in outcomes and treatment engagement across white and Black men with prostate cancer. This is because research suggests that Black men are more likely to die from prostate cancer than white men. This project will consist of two phases. The first phase of the project will analyse routinely collected data from men with prostate cancer. Specifically, we will evaluate whether treatment patterns and outcomes differ between men of different ethnicities with prostate cancer, using national datasets. The second phase will explore key perceptions and practicalities influencing treatment engagement and adherence, and those preventing black men from getting the best from treatments particularly for advanced prostate cancer.
REC name
London - Riverside Research Ethics Committee
REC reference
24/LO/0183
Date of REC Opinion
12 Apr 2024
REC opinion
Further Information Favourable Opinion